Dynasty Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Sell
11,695
-420
-3% -$63K 0.01% 139
2026
Q1
$1.85M Sell
12,115
-94
-0.8% -$14.4K 0.02% 134
2025
Q4
$1.68M Buy
12,209
+579
+5% +$75.8K 0.02% 146
2025
Q3
$1.49M Buy
+11,630
New +$1.42M 0.02% 137

Other funds holding NVS

Dynasty Wealth Management's NVS Position: Q2 2026 in Review

Dynasty Wealth Management reduced its Novartis (NVS) stake by 3.5% in Q2 2026, selling an estimated $63K and leaving 11,695 shares worth $1.83M. The position accounts for 0.01% of the portfolio, ranked #139.

Dynasty Wealth Management first reported a position in NVS in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.85M in Q1 2026. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Dynasty Wealth Management held 11,695 shares of Novartis worth $1.83M as of Q2 2026.
  • Dynasty Wealth Management sold 420 Novartis shares in Q2 2026, an estimated $63K.
  • Novartis made up 0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #139 holding.
  • Dynasty Wealth Management first reported a position in Novartis in Q3 2025 and has held it in 4 quarters since.
  • Dynasty Wealth Management's Novartis position peaked at $1.85M in Q1 2026.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.